Intervention Protocol

Therapeutic and prophylactic drug interventions for Schistosomiasis japonicum

  1. Marissa M Alejandria1,*,
  2. Arthur Dessi Roman2,
  3. Maria Liza M Gonzales3,
  4. Maria Lourdes Amarillo4,
  5. Vicente Y Belizario5,
  6. Qin Liu6

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 12 SEP 2012

DOI: 10.1002/14651858.CD010059


How to Cite

Alejandria MM, Roman AD, Gonzales MLM, Amarillo ML, Belizario VY, Liu Q. Therapeutic and prophylactic drug interventions for Schistosomiasis japonicum (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD010059. DOI: 10.1002/14651858.CD010059.

Author Information

  1. 1

    Department of Medicine, Philippine General Hospital, University of the Philippines, Department of Clinical Epidemiology and Section of Infectious Diseases, Manila, Philippines

  2. 2

    University of the Philippines, Philippines Gneral Hospital, Section of Infectious Diseases, Department of Medicine, Manilla, Philippines

  3. 3

    College of Medicine-Philippine General Hospital, University of the Philippines, Department of Pediatrics, Manila, National Capital Region, Philippines

  4. 4

    University of the Philippines, College of Medicine, Department of Clinical Epidemiology, Manila, Philippines

  5. 5

    University of the Philippines, College of Public Health, Manila, Philippines

  6. 6

    School of Public Health & Management, Chongqing Medical University, China Effective Health Care Network, Chongqing, China

*Marissa M Alejandria, Department of Clinical Epidemiology and Section of Infectious Diseases, Department of Medicine, Philippine General Hospital, University of the Philippines, Manila, 1000, Philippines. issa.alejandria@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 SEP 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To assess the effects of different dosing regimens of praziquantel in terms of clinical cure, parasitological cure, and parasite egg reduction.
  2. To assess the effects of artemisinin derivatives compared to praziquantel alone or in combination, in terms of clinical cure, parasitological cure, and parasite egg reduction.
  3. To assess the effects of praziquantel and artemisinin derivatives, alone or in combination, in preventing S. japonicum infections among at risk population groups.